Clik here to view.
Smiths Medical收购Access Scientific, LLC的业务，壮大血管入路产品阵容
明尼阿波利斯 (美国商业资讯)–全球领先的医疗器械制造商Smiths Medical今天宣布收购Access Scientific, LLC的业务。Access Scientific是广谱血管入路和感染预防领域的一家私有公司，制造POWERWAND™中心静脉和延长留置导管，总部位于加州圣迭戈。POWERWAND™系列产品壮大了Smiths...
View ArticleClik here to view.
Clik here to view.
PROTECT III試験、高リスクPCI前のImpella留置がベイルアウトPCIと比較して死亡率が低いことを示す
米マサチューセッツ州ダンバース （ビジネスワイヤ） —...
View ArticleClik here to view.
Daiichi Sankyo Initiates Clinical Trial with 5th DXd ADC, DS-6157, in...
TOKYO & MUNICH & BASKING RIDGE, N.J. & NASHVILLE, Tenn. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Sarah Cannon Research Institute (Sarah Cannon) announced today...
View ArticleClik here to view.
Fibralign Announces Strategic Partnership With Terumo
UNION CITY, Calif. Fibralign Corp., a Stanford spin-out developer of therapeutic biomedical devices, has announced today that it has executed a long term distributor agreement with Terumo...
View ArticleClik here to view.
フィブラリンがテルモとの戦略的提携を発表
米カリフォルニア州ユニオンシティ （ビジネスワイヤ） — スタンフォード大学からスピンアウトし、治療用バイオメディカルデバイスの開発に当たるフィブラリン・コーポレーションは本日、続発性リンパ浮腫の治療と予防に向けて、BioBridge®（バイオブリッジ）コラーゲンマトリックスを日本で上市・販売するために、テルモ株式会社と長期販売店契約を締結したと発表しました。...
View ArticleClik here to view.
アビオメッド、新しい最高医療責任者（CMO）にチャールズ・サイモントン医師を任命
米マサチューセッツ州ダンバース （ビジネスワイヤ） — Impella心臓ポンプのメーカーであるアビオメッド（Nasdaq: ABMD）は本日、チャールズ（チャック）・サイモントン医師（M.D.）をバイスプレジデント兼最高医療責任者（CMO）に任命したことを発表しました。...
View ArticleClik here to view.
New Partnership: joimax® Joins Forces with JAPAN MEDICALNEXT CO., LTD.
KARLSRUHE, Germany joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting, as of now, a new partnership...
View ArticleClik here to view.
Cell Therapy Tools for Cartilage Repair From Osteoarthritic Knee Joint of...
TOKYO A break through feat of growing pluripotency expressing cells from osteoarthritis (OA) affected cartilage tissue of knee joints of elderly has been reported by orthopedicians and cell culture...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Apyx Medical Corporation Announces Regulatory Clearance to Market and Sell...
CLEARWATER, Fla. Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the...
View ArticleClik here to view.
joimax® Signs National Distribution Partner in Taiwan
KARLSRUHE, Germany joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new countrywide...
View ArticleClik here to view.
Jadeja Scores Century in Partnership with Gavaskar
SANTA CLARA, Calif. Sunil Gavaskar, Legendary Indian Cricketer and Chairman, Board of Governors, Heart to Heart Foundation (H2H Foundation), has scored a century in partnership with Asha Jadeja....
View ArticleClik here to view.
GoLiver Therapeutics的急性肝功能衰竭临床开发和生物制造策略获得欧洲药品管理局(EMA)的肯定性科学建议
法国南特 (美国商业资讯)–GoLiver Therapeutics是一家专注于开发创新治疗药品的初创公司，特别是用于威胁生命的肝脏疾病的细胞疗法产品，而无需使用分化的多能干细胞移植。该公司宣布，欧洲药品管理局(EMA)对于其临床开发、药理毒理学和生产策略计划已给予肯定性科学建议。凭借该肯定性科学建议，GoLiver Therapeutics的临床路线图已达到一个重要的里程碑。...
View ArticleClik here to view.
GoLiver Therapeutics、急性肝不全に対する臨床開発およびバイオ製造戦略につき欧州医薬品庁（EMA）より肯定的な科学的勧告を受領
仏ナント （ビジネスワイヤ） — 革新的医薬品、特に分化多能性幹細胞を使用し、移植を必要とせずに、生命を脅かす肝疾患を治療する細胞治療製品の開発に傾注する新興企業のGoLiver Therapeuticsは、欧州医薬品庁（EMA）が当社の臨床開発／医薬品毒性／製造戦略計画に対する肯定的な科学的勧告を与えたと発表しました。GoLiver...
View ArticleClik here to view.
AVITA Therapeutics Provides Company Update and Preliminary Unaudited Results...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that...
View ArticleClik here to view.
BARDA to Initiate Procurement of the RECELL® System for Emergency Response...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that...
View ArticleClik here to view.
Intralink-Spine, Inc. Adds Clinical Sites in Australia
LEXINGTON, Ky. Intralink-Spine, Inc. (ILS) announces the expansion of clinical trials for their patented injectable medical device, Réjuve ®, intended in Australia for the treatment of low back...
View ArticleClik here to view.
New Study Expands Evidence Demonstrating the Benefits of Critical Congenital...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh,...
View Article